nx-2127
nurix therapeutics
['nx-2127 ']
new data at #eha2022: dr. anthony r. mato presents the methods of uncovering the safety profile, maximum tolerated dose and objective response of promising therapy nx-2127 in a first-in-human phase 1 trial. important dose escalation design and key eligibility criteria revealed! 